Investigation of variability in response to deferiprone(L1) in patients with ß-thalassemia major

Keyphrases

• β-Thalassemia (β-thal) 100%
• Variability in Response 100%
• Vitamin C 100%
• Deferiprone 100%
• Therapeutic Response 66%
• Hepatic Iron Content 66%
• Transfusion Index 66%
• Desferrioxamine 33%
• Iron Overload 33%
• Long-term Treatment 33%
• Therapy Groups 33%
• Aging Index 33%
• Pharmacokinetics 33%
• Observed Variability 33%
• C-level 33%
• Drug Adherence 33%
• Iron Stores 33%
• Compliance Score 33%
• Iron Distribution 33%
• Plasma Vitamin C 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Iron 100%
• Thalassemia Major 100%
• Deferiprone 100%
• Ascorbic Acid 80%
• Deferoxamine 20%
• Pharmacokinetics 20%

Biochemistry, Genetics and Molecular Biology

• Vitamin C 100%
• Cofactor 25%
• Pharmacokinetics 25%
• Iron Storage 25%
• Vitamin Blood Level 25%
• Medication Compliance 25%